DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-06-06 08:00 |
DBV Technologies se félicite de l'arrivée de Véronique Foutel en tant que Direc…
|
French | 78.5 KB | ||
| 2013-06-04 11:00 |
Assemblée Générale Mixte des Actionnaires de la société DBV Technologies du 4 j…
|
French | 128.6 KB | ||
| 2013-06-04 11:00 |
DBV Technologies' June 4th, 2013 Combined Shareholders's Meeting
|
English | 70.6 KB | ||
| 2013-05-16 07:30 |
DBV Technologies et Stallergenes s'associent pour développer des traitements in…
|
French | 142.6 KB | ||
| 2013-05-16 07:30 |
DBV Technologies and Stallergenes enter into partnership for the development of…
|
English | 141.5 KB | ||
| 2013-05-14 08:30 |
ASSEMBLEE GENERALE MIXTE DU 4 JUIN 2013 MODALITES DE MISE A DISPOSITION DES DO…
|
French | 156.7 KB | ||
| 2013-05-07 08:30 |
DBV Technologies et l'Hôpital Mount Sinai concluent un accord de collaboration …
|
French | 136.4 KB | ||
| 2013-05-07 08:30 |
DBV Technologies and Mount Sinai Hospital enter into a Research Collaboration A…
|
English | 87.1 KB | ||
| 2013-04-25 08:31 |
DBV Technologies publishes its 2012 Registration Document and its 2012 Annual …
|
English | 143.4 KB | ||
| 2013-04-25 08:31 |
DBV Technologies publie son document de référence et son Rapport Financier Ann…
|
French | 80.1 KB | ||
| 2013-04-15 08:01 |
DBV Technologies' first quarter 2013 Topline and cash position
|
English | 71.2 KB | ||
| 2013-04-15 08:00 |
Chiffre d'affaires et position de trésorerie de DBV Technologies pour les trois…
|
French | 525.1 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
